No two days are the same here
Founded in 2010, PT. Revass Utama Medika is a distributor & marketing company of cardiology intervention medical device. It began as an importer and distributor of stent and balloon from OrbusNeich Medical (Holding) B.V, Netherlands. As a growing company, PT. Revass do the expansion of its business by distribute another medical accessories as a supporting device for cardiology intervention.
Now, PT. Revass Utama Medika has a big network sales located in 30 major cities of Indonesia archipelago. As our vision to be the best marketing sales and reliable business partners, we serve the best quality product of cardiology intervention medical device in Indonesia.
At end of 2023, we have been collaboration with 259 hospitals around Indonesia, while keep increasing number of hospital coverage
PT Revass is a medical equipment distribution company that currently has a focus on health services for interventional cardiology, peripherals, neuro-vascular, aesthetics and many more. PT Revass has contributed to the distribution of high quality products since 2010, with the motto “One Stop Solution Medical Devices Distributor” PT Revass is highly committed in providing the best solution for the needs of medical devices in Indonesia
- Becoming a trusted business partner and the best medical device distributor in Indonesia.
- Marketing quality interventional cardiology health products.
- Providing solutions for the community for the needs of medical devices, especially in the field of interventional cardiology.
- Creating the best place and pride for employees to work and innovate.
- Providing optimal investment value for investors.
Revass Executive Commissioner
Mr. David CHIEN (錢永勛) is the Chairman, Executive Director and CEO of OrbusNeich. Mr. Chien joined OrbusNeich in February 2000 and is primarily responsible for overseeing the overall strategic planning and policy execution of OrbusNeich.
Mr. Chien has around 27 years of experience in the medical device industry, and was the director of Cordis-Neich Limited from January 1994 to October 1997. He was a director of Tysan Holdings Limited, a company listed on the Stock Exchange (stock code: 0687), from November 1997 to January 2014. Mr. Chien has been the trustee of the Chien Foundation since January 1997 and the governor of KFoundation since July 2019. Mr. Chien was elected as a member of the Board of Trustees of Chung Chi College, the Chinese University of Hong Kong, in 2020.
Mr. Chien studied at York University in Canada.
Mr. Bachder, He has 17 years of experience as a practitioner in finance. He served as CFO at one of the largest media agencies in Indonesia PT WPP Group M for the period 2006 – 2008, as Head of Finance of PT Bakrie Telecom Tbk in 2010, as Chief Financial Officer (CFO) of PT Jatis Piranti Solusindo (a Indonesia Tbk, (April 2022 – Present).subsidiary of Sumitomo Corporation, a leading company in Information Technology and Software Consulting) for the period 2010 – 2012, and as Chief Financial Officer of PT Bakrie Telecom Tbk for the period April 2013 – 2015. Then he founded several companies in the fields of Information Technology, Telecommunications, and Logistics since 2015 until now. In addition, he also served as a Financial Consultant, Investor, and Founder of PT Kedung Group (PT Kedung Artha Lumintu, KedungTranslog Lumintu, Kedung Media Lumintu, Kedung Graha Lumintu), (April 2016 – Present) and Finance Director of PT Seven Gates Indonesia Tbk, (April 2022 – Present).
Revass Executive Director
Mr. Andriatno Martono, He has more than over 20 years of experience in the pharmaceutical and medical devices industry. His career began as a medical representative from 1995 to 2001 at PT Pfizer, then he was trusted as a product manager for cardiovascular and neuro products from 2003 to 2007 at the same company. He was then again trusted as a product manager for cardiovascular, antibiotic, and anesthesia products from 2007 to 2011 at PT Schering Plough Indonesia, and as a product manager for the same line, at PT Merck Sharp Dohme Pharma Tbk in 2012, and he has more than 15 years of experience in interventional cardiology.
Ms. Kwai Ching Denise LAU (劉桂禎) is the Executive Director and Chief Operating Officer of OrbusNeich. She is primarily responsible for leading, overseeing and supervising the operation of OrbusNeich.
Ms. Lau has 21 years of legal, business operation and management experience. Ms. Lau was trained and admitted as a solicitor in Hong Kong in 1999, and was subsequently admitted to practice law in England and Wales and the state of New York in 2000 and 2001, respectively. She worked as an attorney in Paul, Weiss, Rifkind, Wharton & Garrison from 2000 to 2006 and joined Morgan Stanley in February 2006, and left as managing director in April 2015. She joined the Group as the general counsel on April 3, 2018, and has been the senior vice president since April 3, 2018.
Ms. Lau obtained her Bachelor of Law degree from The University of Hong Kong in 1996 and obtained her postgraduate certificate in law from the same university in 1997. Ms. Lau also obtained her Master’s degree in international economic law from the University of Warwick in the United Kingdom in January 2001.
Mr. Wing Shing Jason CHEN (陳泳成) is the Executive Director and Chief Financial Officer of OrbusNeich.
Mr. Chen has over 18 years of experience in auditing, accounting and corporate finance. He joined PricewaterhouseCoopers in December 2003 in the assurance practice and left as senior manager in February 2017. Before joining OrbusNeich, Mr. Chen worked in corporate finance in the property development and investment sector in the PRC. Mr. Chen joined OrbusNeich in April 2017 as the financial controller and was later promoted as the chief financial officer of OrbusNeich in January 2018.
Mr. Chen obtained his bachelor’s degree in business administration, concentrating in financial engineering from The Chinese University of Hong Kong with first class honors in December 2003. He is a certified public accountant in Hong Kong, the State of Washington and the State of Delaware, USA. He is also a charter holder of the Chartered Financial Analyst Institute.
Revass Senior Management
Fundamental principles to achieve the best vision